OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Pulmonary Medicine is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
The persistent problem of persistent air-leaks: approach to management	76
Bronchoscopic treatment of early-stage peripheral lung cancer	43
Home monitoring in asthma: towards digital twins	30
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	29
The role of PET in the management of sarcoidosis	28
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	27
The evolving role of radiological imaging in cystic fibrosis	26
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	22
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	21
Digital outcome measures in pulmonary clinical trials	20
Improving care in lung cancer surgery: a review of quality measures and evolving standards	20
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	20
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	18
Implementation of digital home monitoring and management of respiratory disease	18
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	18
Bronchoscopic diagnosis of peripheral lung lesions	18
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	18
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	17
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	17
Group 2 pulmonary hypertension: from diagnosis to treatment	17
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	16
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	15
Editorial introductions	15
Asthma in pregnancy: a review of recent literature	14
Lung transplant referral considerations for individuals with cystic fibrosis	14

Considerations and clinical management of infections in sarcoidosis	14
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	14
The future of clinical trials in idiopathic pulmonary fibrosis	14
Editorial introductions	14
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	13
Editorial: A future focus on cystic fibrosis in an era of uncertainty despite opportunity	13
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	12
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	12
Casting light on the many facets of sarcoidosis	12
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	12
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	12
Progress for all: addressing disparities in sarcoidosis	12
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	12
Cystic fibrosis liver disease in the post-modulator era	12
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	11
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?	11
Acute rejection post lung transplant	11
Home monitoring of coronavirus disease 2019 patients in different phases of disease	11
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	11
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators	10
Digital inhalers for asthma management	10
Tobacco treatment in the setting of lung cancer screening	10
Imaging in peripheral bronchoscopy	10
What causes cough in pulmonary fibrosis, and how should we treat it?	10
Patterns of progression in non-IPF fibrotic interstitial lung disease	10
Effectiveness and safety of coronavirus disease 2019 vaccines	9
Editorial: Are we ready for prime time?	9
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	9
Multidisciplinary care in nonmalignant central airway obstruction	9
Exhaled breath analysis in interstitial lung disease	9
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	9
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	9
Novel insights in fibrotic pulmonary sarcoidosis	9
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective	9
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	9
Altered pharmacology and toxicology during ageing: implications for lung disease	8
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	8
Adenotonsillectomy: the good, the bad and the unknown	8
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	8
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease	8
The changing landscape of infections in the lung transplant recipient	8
Editorial: ‘What is your occupation?’: historical snippets	8
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	8
Epigenetics and aging: relevance for sleep medicine	8
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	8
The association of preexisting severe asthma with COVID-19 outcomes	8
Infection control in cystic fibrosis: evolving perspectives and challenges	8
Telerehabilitation in pulmonary diseases	8
Right ventricular assessment in pulmonary hypertension	7
Occupational exposures and sarcoidosis: current understanding and knowledge gaps	7

Pulmonary rehabilitation in idiopathic pulmonary fibrosis	7
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	7
Ergonomics in bronchoscopy	7
Telehealth and virtual health monitoring in cystic fibrosis	7
Advancements in airway stents: a comprehensive update	7